Absci (ABSI) Valuation Rank


ABSI Absci Corp ABSI
57 GF Score
Price $11.54
GF Value $1.81
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Absci Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Absci Valuation Rank Related Terms

ABSI
57GF Score
Absci Corp ABSI
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Absci (ABSI) Overvalued in 2026?

Based on GuruFocus' analysis, Absci stock appears to be overvalued. The current stock price of $11.54 is trading 537.3% above its estimated GF Value™ of $1.81. GuruFocus considers Absci to be Significantly Overvalued.

Key valuation signals for ABSI:

  • Valuation Rank:
  • GF Value™: $1.81 vs. price of $11.54 (537.3% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the ABSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Absci Business Description

Address 18105 SE Mill Plain Boulevard, Vancouver, WA, USA, 98683
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
57GF Score

Get the complete analysis for ABSI

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.54
Price
$1.81
GF Value